Evaluating the Use of Low-Dose Naltrexone in Fibromyalgia Patients: Insights and Recommendations
Anthony Raphael
11 Dec 2023 
https://medriva.com/diseases/chronic-diseases/evaluating-the-use-of-low-dose-naltrexone-in-fibromyalgia-patients-insights-and-recommendations/

Low-Dose Naltrexone Researcher Disputes Fibromyalgia Study Negativity
Miriam E. Tucker

December 21, 2023

https://www.medscape.com/viewarticle/low-dose-naltrexone-researcher-disputes-fibromyalgia-study-2023a1000w93

Neuroinflammation expert Jarred Younger, PhD, disputes a recent study commentary calling for clinicians to stop prescribing low-dose naltrexone for people with fibromyalgia.

Low-Dose Naltrexone Improved Memory but Not Pain in Women With Fibromyalgia
Lisa Kuhns, PhD | January 18, 2024
Clinical Pain Advisor
https://www.clinicalpainadvisor.com/interventional-pain-management/low-dose-naltrexone-improved-memory-but-not-pain-in-women-with-fibromyalgia/

Study Finds Low-Dose Naltrexone Works No Better than Placebo  
January 19, 2024
By Pat Anson, PNN Editor
Pain News Network

https://www.painnewsnetwork.org/stories/2024/1/19/danish-study-finds-low-dose-naltrexone-works-no-better-than-placebo

Naltrexone 6 mg Once Daily Versus Placebo in Women with Fibromyalgia: A Randomised, Double-Blind, Placebo-Controlled Trial ¹

Background

Low-dose naltrexone is used to treat fibromyalgia despite minimal evidence for its efficacy. This trial aimed to investigate whether 12-week treatment with 6 mg low-dose naltrexone was superior to placebo for reducing pain in women with fibromyalgia.

Methods